The Label-Free Dream


The most interesting questions in biology — What happens if this is added to a cell? What about this? What about in this cell line? — move beyond characterization and into quantification. When quantifying proteins, researchers have to choose whether or not to label their proteins. Labeling certainly seems like a solid, well-defined route to take. There are plenty of options — ICAT, cICAT, iTRAQ, and SILAC, among others — and overall, labeling tends to offer more precision in results. If you don’t label, well, to begin with you’ve just lost a trendy acronym in your next paper.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.